FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
An FDA advisory committee has unanimously backed Moderna's mRNA-based flu vaccine, marking a significant development for the technology.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
An FDA advisory committee has provided unanimous support for a first-of-its-kind influenza vaccine developed by Moderna. The panel's review process centered on the efficacy and viability of applying mRNA technology to flu prevention.
Coverage from Fierce Biotech, Bloomberg, and AP News confirms the unanimous nature of the committee votes. Reports from Yahoo Finance note that the review process has influenced market activity for Moderna (MRNA) stock.
Coverage does not yet specify a final timeline for formal FDA approval or distribution. Observers are now looking for the agency's official response to the committee's recommendation.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 148d ago.
Quick answers
What technology does the new flu vaccine use?
The vaccine utilizes mRNA technology.
What was the outcome of the FDA advisory committee vote?
The committee voted unanimously to back the candidate.
Has the FDA officially approved the vaccine?
Coverage does not yet specify a final approval decision from the FDA.
Coverage (10)
- Moderna just got a signal investors can’t ignore Yahoo Finance · 148d ago
- FDA panel backs first-of-its-kind flu vaccine using mRNA technology Los Angeles Times · 148d ago
- FDA panel supports first mRNA-based flu vaccine KOMO · 148d ago
- Moderna flu vaccine wins unanimous support from FDA panel BioPharma Dive · 148d ago
- New First-of-Its-Kind Flu Vaccine Approved by FDA Expert Panel ScienceAlert · 148d ago
- Moderna’s flu candidate sails through FDA advisory committee in unanimous votes Fierce Biotech · 149d ago
- Moderna Extends Rally as FDA Advisory Panel Reviews Flu Vaccine Application (MRNA) Yahoo Finance · 149d ago
- Moderna’s mRNA Flu Vaccine Wins FDA Advisory Committee Backing Bloomberg.com · 149d ago
- FDA vaccine panel set to review Moderna mRNA flu shot The Hill · 149d ago
- FDA panel considers a first-of-its-kind flu vaccine using mRNA technology AP News · 149d ago
Topics
Related trends
EXCLUSIVE: US FDA shelves commissioner's voucher program for speedy drug reviews, sources say
The US FDA has shelved its commissioner's priority review voucher pilot program for expedited drug reviews, according to exclusive reporting from Reuters and coverage across multiple outlets.
Christina Applegate fears that ‘poisoning’ may be behind her misdiagnosis of MS
Christina Applegate reveals she is investigating whether breast implant illness caused her multiple sclerosis misdiagnosis, calling it potential 'poisoning.'
FDA orders new warning labels on Ozempic, Wegovy over rare risk of permanent vision loss
Federal regulators mandate new vision loss warning labels across the widely used GLP-1 receptor agonist drug class.
FDA tells GLP-1 makers to warn of potential vision loss side effect
The FDA is requiring all GLP-1 drug makers to add warnings about a possible increased risk of NAION, a rare eye condition that can cause sudden and permanent vision loss.
FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness
Federal regulators issue a new warning regarding GLP-1 medications and a rare eye condition linked to sudden blindness.
US regulator orders makers of weight-loss drugs to carry blindness risk warning
The FDA is requiring all GLP-1 drug makers to add a warning about NAION, a rare eye condition that can cause sudden blindness, to their prescribing information.